The Value of Early Mobilization and Physiotherapy Following Wrist Fractures Treated by Volar Plating
Launched by UNIVERSITY HOSPITAL, AKERSHUS · Dec 13, 2013
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
The study will focus on patients treated with volar locked plating following an extraarticular distal radius fracture.
In a prospective manner the investigators intend to analyze hand function, x-ray and other parameters in order to investigate whether early mobilization and a targeted program of physiotherapy postoperatively leads to a better functional result and earlier return to a normal activity level. The investigators analysis will also focus on the safety of early mobilization with regards to possible detrimental effects on the osteosynthesis, bony union, associated soft-tissue inj...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Position prior to primary reduction:
- • Dorsal tilt \> 25°
- • Radial shortening\> 6 mm
- • Radial inclination reduced by more than 15°
- • Radiocarpal malalignment \> 7 mm
- • Dorsal /volar metaphyseal comminution
- • Volar displacement of the distal fragment(= Smith's fracture)
- Position after initial reduction:
- • Dorsal tilt \> 5°
- • Radial shortening \> 4 mm
- • Radial inclination reduced by more than 10°
- • Radiocarpal malalignment \> 4 mm
- Exclusion Criteria:
- • 1. Gustilo-Anderson type III open fractures
- • 2. Previous distal radius/ulna-fracture and/or disabling hand injury of the same extremity
- • 3. Previous distal radius fracture or other disabling injury to the contralateral side
- • 4. Dementia or other psychiatric illness which affect compliance
- • 5. Congenital anomaly
- • 6. Bilateral radius fracture
- • 7. Concurrent fractures to the upper or lower extremities or other illness which affect movement of the extremities
- • 8. Systemic joint disease such as rheumatoid arthritis
- • 9. Patients who do not speak Norwegian
- • 10. Pathological fracture other than osteoporotic fracture
- • 11. Congenital bone disease (for example osteogenesis imperfecta)
- • 12. Age below 18 and above 70
- • 13. Patients not belonging to Akershus University Hospital
About University Hospital, Akershus
University Hospital Akershus is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative trials. As a part of the University of Oslo, the hospital integrates cutting-edge research with clinical practice, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, University Hospital Akershus is committed to conducting high-quality clinical trials that address critical health challenges and contribute to the development of new therapies and treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, Lorenskog, Norway
Patients applied
Trial Officials
Jan Erik Madsen, Professor
Study Director
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials